NCT00705172View on ClinicalTrials.gov

Retrospective Observational Study on Efficacy and Safety of Norditropin® in Children With Prader-Willi Syndrome

CompletedOBSERVATIONAL

Enrollment

41

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions

Genetic DisorderPrader-Willi Syndrome

Interventions

DRUG

somatropin

Prader-Willi syndrome children treated with at least one dose of Norditropin®

Trial Locations (3)

8006

Zurich

8200

Arhus N

31134

Hildesheim

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY